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Inappropriate ICD shocks are common adverse events; they are mainly due to supraven-
tricular arrhythmias and secondly are related to noise, undersensing, oversensing, device
malfunctions. We present a case of inappropriate device therapy due to myopotential
oversensing in a patient with a subcutaneous ICD (s-ICD). A 58 years old male with an s-ICD
during the device interrogation showed a previous episode of suspected sustained ven-
tricular tachycardia at 210 bpm, which was effectively treated with ICD shock. The patient
experienced the electrical shock while holding a big gas-cylinder in his arms. The EGM
analysis revealed many irregular ventricular signals of low amplitude lasting for 24 s and
interrupted by the shock. The device showed no malfunctions. This is the first case report
of inappropriate S-ICD shock related to myopotential over-sensing. By recording intra-
cardiac EGM, we demonstrated that the noise was created by the activity of the pectorals
muscles.
Copyright © 2015, Cardiological Society of India. All rights reserved.1. Introduction
Inappropriate ICD activation related to rhythm other than
ventricular fibrillation (VF) or sustained ventricular tachy-
cardia (VT) is one of the most common adverse events asso-
ciated with implantable cardioverter defibrillators (ICDs).
Approximately 12e29% of patients with ICDs receive inap-
propriate shocks,1e4 accounting for up to 50% of the total
complications. Inappropriate shocks are primarily due to
tachyarrhythmia e up to 90% of inappropriate shocks2 e and
secondly are due to noise, under-sensing, over-sensing, devicegy, University of Bologna
il.com (A. Corzani).
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ciety of India. All rightsmalfunction and far-field R wave over-sensing.2,5,6 In patients
with ICDs, the most common tachyarrhythmia related to
inappropriate shocks is atrial fibrillation,1,3 followed by sup-
raventricular tachycardia, sinus tachycardia, and non-
sustained VT.1,3 This is the report of a case of inappropriate
device therapy due to myopotential over-sensing in a patient
with subcutaneous ICD (S-ICD). To our knowledge it is the first
report of myopotential over-sensing in a patient with an S-
ICD: there is no other similar case in literature. S-ICD will
probably be a relatively common device in future, therefore
cardiologists should have an adequate knowledge of technical
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This is the story of A.M., male, 58 years old, ischemic dilated
cardiomyopathy, recently implanted with an S-ICD, after a
long medical history of ventricular tachyarrhythmias. He has
history of a large anterior wall myocardial infarction 15 years
back, when angiogram showed a chronic inter-ventricular
anterior coronary branch obstruction and echocardiography
revealed a dilated cardiomyopathy with left ventricular ejec-
tion fraction (EF) equal to 25%. A single chamber ICD was
implanted. Afterwards, despite adequate antiarrhythmic
medical therapy, several sustained slowVT occurred andwere
effectively interrupted by ICD shock. So we decided to ablate
the slow VT and during the ICD replacement we performed an
upgrade to cardiac resynchronization, firstly to reduce the
progression of heart failure and secondly to treat VT with a
more effective biventricular ATP. The latter strategy has been
recently validated by ADVANCE-CRT-D trial.7 Months ago the
patient showed fever with ICD dislodgement and decubitus.
The diagnosis of ICD-related epidermidis-MRSA endocarditis
was confirmed by laboratory cultures and vegetations at
transesophageal echocardiography. After 3weeks of antibiotic
therapy the device was explanted and because of the high risk
of sudden death we decided to implant an S-ICD (Boston Sci-
entific, 1010 SQ-RX). Before the implant a surface EKG
screening for S-ICD was performed and the patient resulted
eligible with 2/3 EKG leads. During the routine device control,
S-ICD interrogation showed one episode of suspected sus-
tainedVTat 210 bpmeffectively treatedwith ICD shock twenty
days before. We asked him if he had experienced the shock,
and he actually remembered a sudden “electrical shaking”
while hewas setting downa gas-cylinder,with brief chest pain
which obliged him to rest on the sofa. The EGM analysis
revealed many irregular ventricular signals of low amplitude
lasting 24 s interrupted by the shock of device; the shock was
followed by sinus rhythm (Fig. 1A). The low amplitude irreg-
ular signals looked like VF or, alternatively, noise. All electrical
parameters of s-ICD were regular, sensing vector was
adequate, the lead systemwas intact and electrode impedance
was stable at 250U (at implant 200U). Duringdevice control,we
confirmed the device therapy settings (the upper-rate cut-off
for the conditional shock zonewas confirmedbetween180 and
209 bpm, with the shock delivery zone upper than 210 bpm).
We asked the patient to accurately describe what he was
doing before feeling the “electrical shock”. He was bending
forward, holding with hands, arms and knees a heavy gas-
cylinder and trying to lift it up for his fish-aquarium. So dur-
ing the visit we reproduced the myopotential over-sensing
asking the patient to repeat the effort holding a gas-cylinder.
We changed the sensitivity of the device through amplifying
the gain and then we changed the sensing vector (passing
from the primary to secondary sensing vector) to avoid inap-
propriate shocks and so we resolved the problem.3. Discussion
The EFFORTLESS S-ICD registry8 collected the data of 472 pa-
tients with s-ICD and reported a relatively low incidence ofinappropriate therapy (rating of 7%), mostly due to inappro-
priate cardiac sensing (5.3%) and supraventricular tachycardia
(1.3%), with a very low incidence of non-cardiac inappropriate
sensing (0.009%). The inappropriate shock rates (7%) in pa-
tients with S-ICD are comparable with the standard trans-
venous ICD studies, registries and trials which range from 4
to 29%.1e4,8e10 While in trans-venous ICDs inappropriate
therapies are primarily due to supraventricular arrhythmias,
in S-ICD the main cause of inappropriate shocks is T-wave
oversensing.
Several discrimination algorithms have been introduced to
traditional ICD without eliminating the problem of inappro-
priate shocks, with still a relatively high incidence despite
detection algorithms (rhythm onset, interval stability, elec-
trogram morphology, and if an atrial lead is present also the
analysis of atrial rates and the relationship between atrial and
ventricular electrograms). The S-ICD has several options for
management of inappropriate shocks without the need for an
invasive procedure including reprogramming of the sensing
vector, and in S-ICD it is possible to choose from 3 different
sensing vectors.
During the visit, when the patient explained what he was
doing, we carefully looked at the EGM and we finally realized
what had really happened. While he was handling the heavy
cylinder, the device delivered inappropriate shock because it
recorded signal over-sensing due to noise of low amplitude
signals related to myopotential. During the visit we asked the
patient to reproduce the up-lifting of an oxygen heavy gas
cylinder, and EGM showed altered ventricular signals, but this
time ICD correctly classified them as “noise” (Fig. 1B), perhaps
because of the minor effort in handling the cylinder. By
recording intracardiac electrocardiogram we demonstrated
that the noise was created by the activity of the pectoral
muscle, because the small amplitude of the muscular poten-
tials was detected by the ICD device as VF.
The problem of over-sensing related to myopotential was
solved by setting a new configuration in device sensitivity. We
changed the sensitivity of S-ICD through amplifying the gain
(“2 gain” selection amplifies the signal twice), and then we
changed the sensing vector passing from “secondary” to
“primary” sensing vector in order to achieve a better sensi-
tivity and to avoid inappropriate shocks. Secondary sensing
vector is the vector from the distal sensing electrode ring on
the subcutaneous electrode to the surface of the active SQ-Rx
device, while primary sensing vector is the vector from the
proximal electrode ring on the subcutaneous electrode to the
surface of the active SQ-RX device. With this new configura-
tion, while the patient held the heavy cylinder tight, no noise
was detected but only a regular sinus rhythm (Fig. 2). This
change in the settings of device has finally solved the problem.
In different studies we observed that the eligibility of the
patients for s-ICD changed if 1 or more leads were consid-
ered suitable in surface EKG screening template. With only
1/3 EKG surface lead, eligibility was reached in 96% of pa-
tients, but considering 2/3 EKG surface leads, eligibility
decreased to 85% and, considering all the leads, eligibility
was 37%.11 This is a key point, in fact in those patients with
one inappropriate shock for over/under-sensing, it is very
important to have a second or a third sensing source.
Moreover we know that EKG has some modifications related
Fig. 1 e A e EGM of s-ICD shock. The EGM analysis revealed many irregular ventricular signals of low amplitude lasting 24 s
interrupted by the shock of device; the shock was followed by sinus rhythm. B e Reproduction of myopotential signals
during the visit. While the patient lifted up the cylinder, EGM showed altered ventricular signals, but this time ICD correctly
classified them as “noise”.
i n d i a n h e a r t j o u r n a l 6 7 ( 2 0 1 5 ) 5 6e5 958to the increase in heart rate, and it may lead to consequent
potential modifications which can preclude eligibility. Un-
fortunately nowadays we have no data about the detection
of malignant arrhythmias which starts during sinus tachy-
cardia. In our opinion it is important to have at least 2/3
leads suitable in surface EKG screening template in order to
minimize the risk of inappropriate shocks, with a better
management of device-related oversensing. So probably theFig. 2 e EGM during effort after new device configuration. With
cylinder, no noise was detected but only regular sinus rhythm. C
be noted (the gain was amplified 2X). (EGM: 25 mm/s; 5 mm/mV2/3 configuration for eligibility may be the best and widely
advisable criterion for eligibility.4. Conclusion
Observing the EGM recorded by patient's device, after having
excluded an episode of VT/VF by linking the EGM trackwith annew sensivity settings, while patient handled the heavy
omparing this EGM to Fig. 1, a higher signal amplitude can
).
i n d i a n h e a r t j o u rn a l 6 7 ( 2 0 1 5 ) 5 6e5 9 59accurate anamnesis, the reasonable suspicion of inappro-
priate shock due to noise related tomyopotential over-sensing
was formulated. By recording intracardiac EGM we demon-
strated that the noise was created by the activity of the pec-
torals muscles and we solved the problem of over-sensing
changing the sensitivity of the device and the sensing vector.
Anamnesis and clinical examination, together with a good
knowledge of the problem, can often overcome advanced
technology.Conflicts of interest
All authors have none to declare.
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